GSK plc (GSK, GSK.L) announced Tuesday new data from the AReSVi-006 (Adult Respiratory Syncytial Virus) phase III trial evaluating ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

GSK (NYSE:GSK) announced Tuesday that Arexvy, a Phase 3 trial for its FDA-approved vaccine against Respiratory Syncytial ...

David Boucher, the director of infectious disease preparedness and response at the Administration for Strategic Preparedness and Response, noted the government recently invested $72 million to boost ...

Activist investor Starboard Value has taken a roughly $1 billion stake in Pfizer and wants the drugmaker to make changes ...

Test results are pending on a worker who had contact with infected herds, California officials report. Meanwhile, federal scientists are studying H5N1 genes in dairy workers in search of mutations ...

Over a 12-month period ending in April, about 101,000 people died after overdosing. More news tied to opioids is about telehealth treatment, tracking prescriptions, gift cards for negative tests, and ...

On Friday, federal health officials announced a significant initiative to bolster the United States' preparedness against potential bird flu outbreak ...

Federal scientists are closely studying H5N1 genetic sequences from California dairy workers in search of any dangerous ...

Current health highlights include Sanofi, GSK, and CSL expanding bird flu vaccine efforts in the U.S. following a multi-state ...

The Biomedical Advanced Research and Development Authority (BARDA) has awarded $72 million to three vaccine companies to boost H5N1 vaccine production. CSL Seqirus, producing a cell-based vaccine, ...

US has announced team up with multinational pharmaceutical companies CSL, GSK, Sanofi, and Seqirus for a $72 million worth of ...